Medifast Reports Q1 2026 Earnings with Revenue Decline and Operational Challenges
Medifast (MED) reported Q1 2026 earnings with a 34.3% year-over-year revenue decline to $76 million, driven by a 44.9% drop in active earning coaches. Despite this, average revenue per coach increased by 19.2% year-over-year, and the company saw a 35.6% reduction in SG&A expenses. The results reflect ongoing challenges from GLP-1 disruption and leadership restructuring.
Topics: Active Earning Coaches Cash and Investments Coach Productivity Gross Profit Net Loss Operating Loss Revenue Decline SG&A Expense